ResMed Inc. (RMD)

Every figure this model derived for RMD, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 156,285,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 1,469,234,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 4,324,739,000 AssetsCurrent 2026-06-30
current liabilities 1,395,110,000 LiabilitiesCurrent 2026-06-30
equity 6,585,393,000 StockholdersEquity 2026-06-30
interest expense 27,057,000 InterestPaidNet 2026-06-30
ocf 1,805,829,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 5,653,443,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 104,348,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up RMD on one particular measure came for.

RatioValue
cash operating margin38.78
current ratio3.51
current ratio reported3.1
deferred revenue growth-1.88
dilution pct-0.87
ebit cagr17.19
ebit yoy11.95
fcf margin29.18
growth cv0.25
interest cover69.73
operating margin33.37
owner earnings margin27.33
revenue growth9.85
revenue growth per share10.82
roic25.81
rule of 4043.23
sbc pct revenue1.85

What to be careful about

What this model itself distrusts about RMD's figures. Written by the derivation as it ran, not added afterwards.